What We’re Reading: Lowering Drug Prices; FDA Limits Alzheimer Drug Recipients; Western States Brace for Heat Wave
President Joe Biden is expected to sign an executive order aimed at lowering drug prices; the FDA imposes limits on who should receive a controversial new Alzheimer disease drug; western US states prepare for a second heat wave.
Biden Takes on Drug Prices
As part of an executive order he is expected to sign today, President Joe Biden will call on federal health officials to increase their efforts to lower prescription drug prices,
FDA Revises Alzheimer Drug Indication
Following backlash on its broad indication for the newly approved and controversial Alzheimer drug aducanumab (
States Prepare for Another Blistering Heat Wave
After a
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025
- Eating Behaviors May Predict GLP-1 Therapy Success in Type 2 Diabetes
September 18th 2025